View Author
patient study factor university thrombosis mutation protein hospital leiden disease deficiency association variant department level control center survival prothrombin gene mutation portal dosing syndrome health netherland liver table number budd-chiari syndrome protein c deficiency coumarin research disorder prothrombin analysis blood risk factors anticoagulation medicine diagnosis portal vein thrombosis treatment result therapy warfarin cyp 2c trial venou group institute algorithm allele risk factor hepatic month myeloproliferative coumarin derivatives leiden university budd-chiari heart outcome science meta-analysi vkorc antithrombin obstruction range stxbp genetic stxbp 5 janssen replication genome-wide design plasma model value article protein c incident vt thrombotic
6 Most Recent Publications
|
Genetic variation associated with plasma vonWillebrand factor levels and the risk of incident venous thrombosis
(Article)
Smith, N.L. Rice, K.M. Dehghan, A. Strachan, D.P. O'Donnell, C.J. Rotter, J.I. Heckbert, S.R. Psaty, B.M. Rosendaal, F.R. Bovill, E.G. Cushman, M. Bis, J.C. McKnight, B. Lumley, T. Glazer, N.L. Hylckama Vlieg, A. van Tang, W. |
2011-06-02
|
|
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
(Article)
Schunkert, H. König, I.R. Absher, D. Peters, A. Peyvandi, F. Qu, L. Quyyumi, A.A. Rader, D.J. Rallidis, L.S. Rice, C. Rosendaal, F.R. Rubin, D. Salomaa, V. Aherrahrou, Z. Sampietro, M.L. Sandhu, M.S. Schadt, E.E. Scḧsignfer, A. Schillert, A. Schreiber, S. Schrezenmeir, J. Schwartz, S.M. Siscovick, D.S. Sivananthan, M. Allayee, H. Sivapalaratnam, S. Smith, A.V. Snoep, J.D. Soranzo, N. Spertus, J.A. Stark, K. Stirrups, K. Stoll, M. Tang, W.H.W. Tennstedt, S. Altshuler, D. Thorgeirsson, G. Thorleifsson, G. Tomaszewski, M. Uitterlinden, A.G. Rij, A.M. van Voight, B.F. Wareham, N.J. Wells, G. Wichmann, H.E. Wild, P.S. Anand, S.S. Willenborg, C. Witteman, J.C.M. Wright, B.J. Ye, S. Zeller, T. Ziegler, A. Cambien, F. Goodall, A.H. Cupples, L.A. Quertermous, T. Andersen, K. Mäsignrz, W. Hengstenberg, C. Blankenberg, S. Ouwehand, W.H. Hall, A.S. Kastelein, J.J.P. Deloukas, P. Thompson, J.R. Stefansson, K. Roberts, R. Anderson, J.L. Thorsteinsdottir, U. O'Donnell, C.J. McPherson, R. Erdmann, J. Samani, N.J. Ardissino, D. Ball, S.G. Balmforth, A.J. Kathiresan, S. Barnes, T.A. Becker, D.M. Berger, K. Bis, J.C. Boekholdt, S.M. Boerwinkle, E. Braund, P.S. Brown, M.J. Burnett, M.S. Buysschaert, I. Reilly, M.P. Carlquist, J.F. Chen, L. Cichon, S. Codd, V. Davies, R.W. Dedoussis, G.V. Dehghan, A. Demissie, S Devaney, J. Diemert, P. Assimes, T.L. Do, R. Doering, A. Eifert, S. Mokhtari, N.E.E. Ellis, S.G. Elosua, R. Engert, J.C. Epstein, S.E. Faire, U. de Fischer, M. Holm, H. Folsom, A.R. Freyer, J. Gigante, B. Girelli, D. Gretarsdottir, S. Gudnason, V. Gulcher, J.R. Halperin, E. Hammond, N. Hazen, S.L. Preuss, M. Hofman, A. Horne, B.D. Illig, T. Iribarren, C. Jones, G.T. Jukema, J.W. Kaiser, M.A. Kaplan, R. Khaw, K-T. Knowles, J.W. Stewart, A.F.R. Kolovou, G. Kong, A. Laaksonen, R. Lambrechts, D. Leander, K. Lettre, G. Li, X. Lieb, W. Loley, C. Lotery, A.J. Barbalic, M. Mannucci, P.M. Maouche, S. Martinelli, N. McKeown, P.P. Meisinger, C. Meitinger, T. Melander, O. Merlini, P.A. Mooser, V. Morgan, T. Gieger, C. Mühleisen, T.W. Muhlestein, J.B. Münzel, T. Musunuru, K. Nahrstaedt, J. Nelson, C.P. Nöthen, M.M. Olivieri, O. Patel, R.S. Patterson, C.C. |
2011-02-01
|
|
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
(Article)
Schie, R.M.F. van Wadelius, M. Briz, M. Rosendaal, F.R. Redekop, W.K. Pirmohamed, M. Maitland-van der Zee, A-H. Kamali, F. Daly, A.K. Manolopoulos, V.G. Boer, A. de Barallon, R. Verhoef, T.I. Kirchheiner, J. Haschke-Becher, E. |
2009-10-01
|
|
Etiology, management, and outcome of the Budd-Chiari syndrome
(Article)
Murad, S.D. Plessier, A. Hadengue, A. Langlet, P. Miranda, H. Primignani, M. Elias, E. Leebeek, F.W.G. Rosendaal, F.R. Garcia-Pagan, J.C. Valla, D.C. Janssen, H.L.A. Hernandez-Guerra, M. Fabris, F. Eapen, C.E. Bahr, M.J. Trebicka, J. Morard, I. Lasser, L. Heller, J. |
2009-01-01
|
|
Extrahepatic portal vein thrombosis: aetiology and determinants of survival
(Article)
Janssen, H.L.A. Hansen, B.E. Vleggaar, F.P. Wijnhoud, A.D. Hoek, B. van Rosendaal, F.R. Haagsma, E.B. Uum, S.H. van Nieuwkerk, C.M. van Adang, R.P.R. Chamuleau, R.A. Hattum, J. van |
2001-01-01
|
|
Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study
(Article)
Janssen, H.L.A. Vandenbroucke, J.P. Chamuleau, R.A. Adang, R.P.R. Rosendaal, F.R. Hoek, B. van Meinardi, J.R. Vleggaar, F.P. Uum, S.H. van Haagsma, E.B. Meer, F.J.M. van der Hattum, J. van |
2000-01-01
|
